Rhythm Pharmaceuticals Inc (RYTM)
Healthcare
Biotechnology
102.80 $
+3.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Rhythm Pharmaceuticals Inc (RYTM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -116 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.5 | -7.0 | -23 | -29 | -62 | -123 | -122 | -146 | -173 | -136 | -114 | -116 | |
| 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.8 | 0.7 | 1.2 | 1.7 | 1.8 | 1.6 | 1.3 | |
| 0.1 | 0.3 | 1.2 | 2.3 | 6.4 | 12 | 17 | 21 | 20 | 33 | 40 | 67 | |
| 0.1 | 1.7 | 1.2 | 4.1 | 6.4 | 12 | 17 | 21 | 20 | – | – | – | |
| -0.8 | 2.4 | 1.3 | 0.0 | 0.7 | 5.1 | -5.9 | 1.9 | -20 | 4.8 | 11 | -1.0 | |
| 0.0 | 0.0 | 1.1 | 0.1 | 0.7 | 3.4 | 0.2 | 5.4 | 4.3 | 0.0 | 0.0 | 1.0 | |
| 0.0 | 0.0 | -5.1 | -110 | -87 | -28 | 159 | -62 | 28 | -5.7 | -48 | -137 | |
| – | – | – | 0.0 | – | – | – | – | – | – | 4.0 | 5.4 | |
| 7.4 | 42 | 126 | 167 | 165 | 163 | 2.0 | 166 | 141 | – | – | – | |
| – | – | – | – | – | – | – | – | 72 | – | – | – | |
| 7.4 | 42 | 0.0 | 167 | 165 | 163 | 2.0 | 166 | 214 | 74 | 191 | 218 | |
| -0.1 | 35 | -28 | 28 | 15 | 13 | 39 | -42 | 68 | -68 | 29 | -35 | |
| -7.5 | -7.0 | -24 | -30 | -63 | -126 | -122 | -151 | -178 | -136 | -114 | -117 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.